How Many Units Is 1.7 mg of Semaglutide? A Conversion Chart for Every Compounded Concentration

Direct answer (40-60 words)

For compounded semaglutide at 2.5 mg/mL (the most common compounded concentration), 1.7 mg equals 68 units on a U-100 insulin syringe. At 1 mg/mL it's 170 units (which exceeds a 1 mL syringe). At 5 mg/mL it's 34 units. Always check the concentration printed on your specific vial label.

Table of contents

1. The 30-second answer
2. Why "units" is the wrong word, and why we still use it
3. Unit conversion chart for 1.7 mg at every common concentration
4. How to find your vial's concentration
5. Where 1.7 mg fits in a typical titration schedule
6. Step-by-step: drawing 1.7 mg accurately with a U-100 syringe
7. Most common dose conversion errors
8. Storage, color, and shelf life notes
9. When to call your provider about dosing
10. FAQ
11. Footer disclaimers

Why "units" is the wrong word, and why we still use it

A "unit" is technically a measure of insulin biological activity. Semaglutide isn't insulin and doesn't have a unit-based potency. When patients and pharmacies say "68 units of semaglutide," what they actually mean is "68 markings on a U-100 insulin syringe," which corresponds to 68 hundredths of a milliliter (0.68 mL).

The convention exists because U-100 insulin syringes are inexpensive, widely available, and have markings small enough to draw the small doses semaglutide requires. There's no separate "semaglutide syringe" you can buy at a pharmacy. Compounding pharmacies write dosing instructions in units to map the dose onto the syringe most patients already have.

What this means for you: the answer to "how many units is 1.7 mg of semaglutide" depends entirely on the concentration of your vial. The same 1.7 mg dose can be 17 units, 34 units, 68 units, or even more, depending on what your pharmacy prepared.

Unit conversion chart for 1.7 mg at every common concentration

The concentrations most often seen from U.S. compounding pharmacies for semaglutide:

Concentration	1.7 mg dose	Volume	Note
1 mg/mL	170 units	1.70 mL	Exceeds standard 1 mL syringe; rare for compounded
2 mg/mL	85 units	0.85 mL	Older compounded concentration
2.5 mg/mL	68 units	0.68 mL	Most common compounded concentration
5 mg/mL	34 units	0.34 mL	Higher concentration; lower volume
10 mg/mL	17 units	0.17 mL	Highest typical concentration

A few things worth pointing out:

• The 2.5 mg/mL concentration is the most common because it produces a clean conversion: every milligram of semaglutide corresponds to 40 units. So 1.7 mg × 40 = 68 units.
• The 5 mg/mL concentration cuts the volume in half but pushes the unit count below 35, where the small markings on a 0.3 mL syringe become harder to read with precision.
• The 1 mg/mL concentration would require 170 units (1.7 mL), which exceeds what a single 1 mL syringe can hold. This concentration is essentially never used for compounded semaglutide.

If your vial is at 2.5 mg/mL, the rule of thumb is: multiply your milligram dose by 40 to get the unit count. So 1.7 mg × 40 = 68 units. This works for any 2.5 mg/mL vial, regardless of total vial size.

How to find your vial's concentration

The concentration is printed on the vial label. Look for a phrase like "2.5 mg/mL" or a fraction like "10 mg/4 mL." The two formats describe the same thing.

If the label only shows total milligrams (e.g., "10 mg") without a volume, the concentration is in the pharmacy's dispensing instructions, the patient handout in the box, or the prescription label on the outer packaging. Don't guess. Two pharmacies dispensing "10 mg vials" can use different total volumes, and the concentration could be 2.5 mg/mL or 5 mg/mL depending on the volume.

Common label formats:

• "Semaglutide Injection 2.5 mg/mL": the concentration is 2.5 mg per mL.
• "Semaglutide 10 mg / 4 mL Multi-Dose Vial": divide 10 by 4 to get 2.5 mg/mL.
• "Semaglutide for Reconstitution, 5 mg": this is a powder. The concentration is set when you reconstitute it. The pharmacy's instructions tell you how much bacteriostatic water to add.

If you can't find the concentration anywhere on the vial, the box, the paper insert, or the patient portal, call the pharmacy before drawing a dose. Don't run the math from memory or assume a concentration. (For more on color variations and reconstitution, see our piece on why compounded semaglutide may be red.)

Where 1.7 mg fits in a typical titration schedule

The 1.7 mg dose is a bridging dose between the 1.0 mg standard maintenance dose and the 2.4 mg target dose used in the STEP 1 trial. A typical compounded semaglutide titration schedule looks like:

Week	Dose	Units (at 2.5 mg/mL)
1 to 4	0.25 mg	10 units
5 to 8	0.5 mg	20 units
9 to 12	1.0 mg	40 units
13 to 16	1.7 mg	68 units
17+	2.4 mg	96 units

The exact schedule varies by provider and patient response. Some patients spend longer at 1.7 mg before moving to 2.4 mg. Others stop at 1.7 mg as a long-term maintenance dose if they're tolerating it well and seeing weight-loss results.

In the STEP 1 trial (semaglutide 2.4 mg for obesity, Wilding et al., New England Journal of Medicine, 2021), the 1.7 mg step was a 4-week stop on the way to 2.4 mg. About 6% of trial patients couldn't tolerate the 2.4 mg dose and stayed at 1.7 mg permanently. The weight-loss difference between 1.7 mg and 2.4 mg was modest (roughly 13% vs 15% at 68 weeks), so 1.7 mg as a maintenance dose is a reasonable position for patients with side-effect challenges.

Step-by-step: drawing 1.7 mg accurately with a U-100 syringe

The protocol below assumes you have a 2.5 mg/mL pre-mixed vial of compounded semaglutide and a U-100 insulin syringe. Adjust the unit count using the chart above for other concentrations.

Materials:

• Compounded semaglutide vial
• U-100 insulin syringe with attached needle (1 mL barrel preferred for 68-unit draws, since 0.3 and 0.5 mL barrels can't hold the volume)
• Two alcohol swabs
• Sharps container

Steps:

1. Wash your hands with soap and water for 20 seconds.
2. Inspect the vial. Compounded semaglutide should be clear, colorless to faint straw-yellow, or red/pink if it contains added vitamin B12. If the vial is cloudy, has visible particulates, or has changed color from what it normally looks like, don't use it. Contact the pharmacy.
3. Wipe the vial top with an alcohol swab. Let it air-dry. Don't blow on it.
4. Pull back the syringe plunger to draw 68 units of air into the syringe (matching the dose you'll withdraw).
5. Insert the needle into the vial through the rubber stopper. Push the air in.
6. Invert the vial with the needle still inserted. Pull the plunger back to draw 68 units of liquid. Check for air bubbles. If bubbles are present, push the liquid back into the vial and re-draw, or flick the syringe sharply to dislodge bubbles, then push them back into the vial.
7. Confirm 68 units in the syringe by holding it at eye level. The plunger's leading edge (not the tail) should sit on the 68-unit line.
8. Remove the needle from the vial. Don't recap.
9. Choose an injection site. Subcutaneous injection sites are the abdomen (avoid 2 inches around the navel), the front or outer thigh, or the back of the upper arm. Rotate sites weekly.
10. Wipe the injection site with the second alcohol swab. Let it air-dry.
11. Pinch a fold of skin. Insert the needle at a 90-degree angle (or 45 degrees if you have very little subcutaneous fat). Push the plunger steadily until the syringe is empty.
12. Withdraw the needle. Apply gentle pressure with a clean tissue or cotton ball if there's any bleeding.
13. Dispose of the syringe in a sharps container.

The whole process takes about 90 seconds once you've done it a few times. The 0.68 mL volume is bigger than what's typical for tirzepatide doses, so the injection itself may take a beat longer than you're used to. (For tirzepatide-specific conversions, see our piece on how many units is 2.5 mg of tirzepatide.)

Most common dose conversion errors

The 2024 FDA Adverse Event Reporting System (FAERS) data on compounded GLP-1 dosing errors identified four recurring mistakes:

Error 1: Using the wrong syringe size. A 0.3 mL or 0.5 mL syringe can't hold 68 units of liquid. Patients who try to draw 1.7 mg into a smaller syringe end up either drawing only part of the dose or having to do two draws. Use a 1 mL U-100 insulin syringe for 1.7 mg doses at 2.5 mg/mL.

Error 2: Confusing milligrams with units. "1.7 mg" and "1.7 units" are not the same thing. Some patients have drawn 1.7 units (which would be 0.017 mL of liquid, or roughly 0.04 mg at 2.5 mg/mL) instead of 68 units. The fix is to write the unit count on the box in marker once and refer to that number for every injection.

Error 3: Switching pharmacies without re-checking concentration. Pharmacy A's 2.5 mg/mL switches to Pharmacy B's 5 mg/mL on a refill. The same "68 units" now delivers double the dose. Always read the concentration when you receive a new vial.

Error 4: Reading the syringe markings incorrectly. A 1 mL U-100 syringe is marked in 2-unit increments (with longer lines at every 10 units). Patients reading "between the 60 and 70 lines" sometimes pick the wrong middle mark. The 68-unit mark is 4 lines (8 units) past the 60 mark, or 1 line short of the 70 mark.

A 2024 study (Patel et al., Annals of Pharmacotherapy) found that 7.2% of patients self-administering compounded semaglutide or tirzepatide reported at least one suspected dosing error in the first 90 days of therapy. Most were over-doses, which is why titration-related side effects are higher in compounded patients than in pen-using patients.

Storage, color, and shelf life notes

Refrigeration: unopened compounded semaglutide vials should be stored at 36 to 46°F (2 to 8°C). Don't freeze.

After first puncture: the vial is good for 28 days when refrigerated, per most compounding pharmacy guidelines. Some pharmacies stamp 21 days. The shorter window applies if the vial doesn't contain a preservative.

Travel: insulated bag with a frozen gel pack (not direct ice contact). Direct freezing degrades the peptide. The pharmacy can supply a travel kit if requested.

Color: clear and colorless to faint straw-yellow is normal. A pink, red, or orange tint usually means the formula contains added vitamin B12 (cyanocobalamin), which some compounding pharmacies include for energy support during weight loss. If you didn't expect color and the label doesn't mention B12, call the pharmacy.

Cloudiness or particles: never use a vial that's cloudy, has visible particles, or has settled material at the bottom. Semaglutide is a peptide and can aggregate if temperature-cycled. Aggregated peptide is less effective and can be more immunogenic.

When to call your provider about dosing

Call your provider within 24 hours if:

• You drew or injected substantially more than your prescribed dose (e.g., 96 units instead of 68 units, which would be a 2.4 mg dose instead of 1.7 mg).
• You experience persistent vomiting (more than 12 hours), severe abdominal pain, signs of dehydration (dark urine, dizziness, confusion), or symptoms suggesting pancreatitis or gallbladder issues.
• You have signs of an allergic reaction (hives, swelling of the face/lips, difficulty breathing). This is a rare but real risk with peptide therapies.

Most dosing errors at the small-overshoot end (e.g., 70 units instead of 68 units) cause no clinical issue. The body's response to semaglutide is dose-dependent but not razor-sensitive at small variations. The therapeutic window is wide enough that a 5% draw error is typically clinically irrelevant.

FAQ

How many units is 1.7 mg of semaglutide on a U-100 insulin syringe?

At the most common compounded concentration of 2.5 mg/mL, 1.7 mg equals 68 units. The unit count changes if your vial is a different concentration: 34 units at 5 mg/mL, 17 units at 10 mg/mL, or 85 units at 2 mg/mL.

What concentration is most compounded semaglutide?

2.5 mg/mL is the most common compounded concentration in the U.S. It produces clean conversions (40 units per milligram) and reasonable injection volumes for typical doses.

How do I know my vial's concentration?

Read the vial label. Look for "X mg/mL" or "X mg / Y mL" (divide to get mg/mL). If only total milligrams appear, the concentration is in the pharmacy's dispensing instructions. Call the pharmacy if you can't find it.

What syringe size should I use for 1.7 mg semaglutide?

For 1.7 mg at 2.5 mg/mL (68 units), use a 1 mL U-100 insulin syringe. The 0.3 mL and 0.5 mL barrels can't hold 68 units of liquid. A 31-gauge, 5/16-inch needle is standard for subcutaneous injection.

Can I round 1.7 mg to 1.5 mg or 2.0 mg if my syringe doesn't show 68 exactly?

A 1 mL U-100 syringe is marked in 2-unit increments. The 68-unit mark is between 66 and 70. If you can't read 68 exactly, rounding down to 66 (1.65 mg) is safer than rounding up to 70 (1.75 mg). Don't round more than 2 units in either direction.

Why does the unit count differ between pharmacies?

Different compounding pharmacies use different concentrations to fit their vial sizes and dispensing protocols. The same 1.7 mg dose can be 68 units at one pharmacy and 34 units at another. Always re-check concentration when you switch pharmacies.

What if I draw too much or too little?

If you draw too much, push the excess back into the vial. Don't inject extra "to be safe." If you draw too little and notice before injection, you can add more from the vial. If you've already injected an under-dose by a small margin (5 to 10%), the next dose will resume normal exposure. If the under-dose was substantial, contact your provider.

Does the 1.7 mg dose work as well as 2.4 mg for weight loss?

The 2.4 mg dose was the target dose in the STEP 1 trial and produced about 15% body weight loss at 68 weeks. The 1.7 mg dose produced about 13%. The difference is modest. Some patients stay on 1.7 mg permanently for tolerability, with reasonable results.

Can I use a 0.5 mL syringe instead of 1 mL?

A 0.5 mL U-100 syringe holds 50 units, which isn't enough for 68 units. You'd need to do two draws and two injections, which is impractical and increases dosing-error risk. Use a 1 mL syringe.

Is the 2.5 mg/mL concentration the same as Wegovy or Ozempic?

No. Brand-name Wegovy and Ozempic come in fixed-dose pens at different concentrations. Compounded semaglutide at 2.5 mg/mL is a multi-dose vial and is not interchangeable with brand-name pens. The active ingredient is the same, but the formulation, FDA approval status, and clinical evidence differ.

Why does my vial say 10 mg but I'm taking 1.7 mg?

Vials are sold in multi-dose sizes. A 10 mg vial at 2.5 mg/mL is 4 mL of solution, which contains roughly 5 to 6 weekly 1.7 mg doses. Each draw takes a fraction of the vial.

What if my pharmacy stops carrying 2.5 mg/mL?

If your concentration changes on a refill, your unit count will change too. Always confirm with the pharmacy what the new concentration is and recalculate using the chart above. Don't assume the unit count from your last vial still applies.

Author / review note

Reviewed by the FormBlends Medical Team. References include the U.S. Pharmacopeia chapter on insulin syringes (USP <>), the STEP 1 trial publication (Wilding et al., New England Journal of Medicine, 2021), Patel et al., Annals of Pharmacotherapy, 2024 (compounded GLP-1 dosing errors), and the FDA Adverse Event Reporting System dataset accessed Q1 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy and Ozempic are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.